The US Food and Drug Administration last week approved two HIV-1 viral load prognostic tests from Roche and Abbott.
Following the approval of its Cobas AmpliPrep/Cobas TaqMan HIV-1 Test, Roche highlighted that its fully automated HIV-1 diagnostic tool using PCR technology is the first of its kind and an improvement over earlier-generation tests because it yields a wider range of viral load data.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
